Feasibility of autologous intraoperative blood collection and retransfusion in small children with complex congenital heart defects undergoing cardiopulmonary bypass

Allogeneic blood product transfusion is common in pediatric patients undergoing cardiopulmonary bypass although it is associated with an increased risk for adverse events. Furthermore, numerous donor exposures may affect future blood transfusion needs and human leukocyte antigen matching for patients who may ultimately require cardiac transplantation. Autologous intraoperative blood collection and retransfusion is a known method of blood preservation, but has not been extensively practiced in pediatric patients. In this study we assess the feasibility of this blood conservation technique in small children with complex congenital heart defects undergoing cardiopulmonary bypass.

[1]  A. Troisi.  Current Problems and Future Directions , 2020 .

[2]  A. Zangrillo,et al.  Acute Normovolemic Hemodilution Reduces Allogeneic Red Blood Cell Transfusion in Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Trials , 2017, Anesthesia and analgesia.

[3]  S. Stowell,et al.  Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience. , 2017, Archives of pathology & laboratory medicine.

[4]  J. Tobias,et al.  Revisiting acute normovolemic hemodilution and blood transfusion during pediatric cardiac surgery: a prospective observational study , 2017, Paediatric anaesthesia.

[5]  F. Jung,et al.  Products , 1968, ADHESION ADHESIVES&SEALANTS.

[6]  T. Sundt,et al.  Greater Volume of Acute Normovolemic Hemodilution May Aid in Reducing Blood Transfusions After Cardiac Surgery. , 2015, The Annals of thoracic surgery.

[7]  J. Tobias,et al.  A single‐center strategy to minimize blood transfusion in neonates and children undergoing cardiac surgery , 2015, Paediatric anaesthesia.

[8]  Elizabeth C. Wilson,et al.  Excessive Postoperative Bleeding and Outcomes in Neonates Undergoing Cardiopulmonary Bypass , 2015, Anesthesia and analgesia.

[9]  K. Maher,et al.  Early postoperative bleeding is independently associated with increased surgical mortality in infants after cardiopulmonary bypass. , 2014, The Journal of thoracic and cardiovascular surgery.

[10]  M. Karimi,et al.  Blood conservation operations in pediatric cardiac patients: a paradigm shift of blood use. , 2013, The Annals of thoracic surgery.

[11]  J. Zimring,et al.  Current problems and future directions of transfusion‐induced alloimmunization: summary of an NHLBI working group , 2011, Transfusion.

[12]  F. Pigula,et al.  Blood transfusion after pediatric cardiac surgery is associated with prolonged hospital stay. , 2011, The Annals of thoracic surgery.

[13]  C. Hillyer,et al.  HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease , 2009, Pediatric blood & cancer.

[14]  R. Friesen,et al.  A trial of fresh autologous whole blood to treat dilutional coagulopathy following cardiopulmonary bypass in infants , 2006, Paediatric anaesthesia.

[15]  A. Shander,et al.  The Safety and Efficacy of “Bloodless” Cardiac Surgery , 2005, Seminars in cardiothoracic and vascular anesthesia.

[16]  E. Øvrum,et al.  Quality of intraoperative autologous blood withdrawal used for retransfusion after cardiopulmonary bypass. , 2003, The Annals of thoracic surgery.

[17]  Paul R. Rosenbaum,et al.  Optimal Matching for Observational Studies , 1989 .

[18]  L. Hill,et al.  Prevention of refractoriness and HLA-alloimmunization using filtered blood products. , 1988, Blood.

[19]  E. Everett,et al.  Class I HLA molecules on human erythrocytes. Quantitation and transfusion effects. , 1987, Transplantation.

[20]  P. Rebulla,et al.  The Clinical Importance of Leukocyte Depletion in Regular Erythrocyte Transfusions , 1986, Vox sanguinis.